Results 161 to 170 of about 48,073 (302)

Heterogenous Dopamine D2 Receptor Subtype Messenger Ribonucleic Acid Expression in Clinically Nonfunctioning Pituitary Adenomas1 [PDF]

, 1998
Ulrich Renner, Thomas Arzberger, Uberto Pagotto, Susanne Leimgruber, Eberhard Uhl, Adolf Müller, Manfred Lange, A. Weindl, Günter K. Stalla   +8 more
openalex   +1 more source

Acute care of cyclic vomiting syndrome and cannabinoid hyperemesis syndrome in the home and emergency department

Neurogastroenterology &Motility, Volume 37, Issue 3, March 2025.
Abstract Background Cyclic vomiting syndrome (CVS) and cannabinoid hyperemesis syndrome (CHS) are both characterized by episodic, acute transitions from asymptomatic states to highly symptomatic states of nausea, repetitive vomiting, and often severe abdominal pain.
David J. Levinthal, Blynda Killian, Robert M. Issenman   +2 more
wiley   +1 more source

Association between dopamine receptor D2 Taq IA gene polymorphism (rs1800497) and personality traits. [PDF]

SAGE Open Med
Olasore HSA, Oyedeji TA, Faleti JO, Ogundele OI, Olashore AA.   +4 more
europepmc   +1 more source

Effects of intravenous injection of dopamine D2 receptor agonists on striatal neurons of rats.

, 1993
Hiroaki Matsubayashi, Taku Amano, Masashi Sasa   +2 more
openalex   +1 more source

Lack of Discrimination by Agonists for D2 and D3 Dopamine Receptors [PDF]

, 1995
Kevin D. Burris, Mary A. Pacheco, Theresa M. Filtz, Mei‐Ping Kung, Hank F. Kung, Perry B. Molinoff   +5 more
openalex   +1 more source

Endocannabinoid signaling in stress, nausea, and vomiting

Neurogastroenterology &Motility, Volume 37, Issue 3, March 2025.
Abstract Background Classical antiemetics that target the serotonin system may not be effective in treating certain nausea and vomiting conditions like cyclic vomiting syndrome (CVS) and cannabinoid hyperemesis syndrome (CHS). As a result, there is a need for better therapies to manage the symptoms of these disorders, including nausea, vomiting, and ...
Marieka V. DeVuono, Thangam Venkatesan, Cecilia J. Hillard   +2 more
wiley   +1 more source

Dopamine receptor D2 confers colonization resistance via microbial metabolites. [PDF]

Nature
Scott SA, Fu J, Chang PV.
europepmc   +1 more source

Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. [PDF]

Cancers (Basel), 2020
Hu W, Zhang L, Ferri-Borgogno S, Kwan SY, Lewis KE, Cun HT, Yeung TL, Soliman PT, Tarapore RS, Allen JE, Guan X, Lu KH, Mok SC, Au-Yeung CL.   +13 more
europepmc   +1 more source

Inhibitory control of prolactin and Pit-1 gene promoters by dopamine. Dual signaling pathways required for D2 receptor-regulated expression of the prolactin gene.

, 1991
Harry P. Elsholtz, Andrew M. Lew, Paul R. Albert, V.C. Sundmark   +3 more
openalex   +1 more source

PharmGKB summary [PDF]

Pharmacogenetics and Genomics, 2011
Teri E. Klein, Russ B. Altman, Katrin Sangkuhl, Paul Thomas, Huaiyu Mi, Huijun Z. Ring, Ruhong Jiang   +6 more
openaire   +3 more sources